In [194], Santos et al. studied the expression of the Syndecan family in PCa tissues, finding that the overexpression of Syndecan-1 (as well as Syndecan-3) was associated with more aggressive tumors and a worse prognosis, and more precisely with decreased recurrence-free survival. This evidence concerns the gene SDC1 and posterior cortical atrophy.